Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial. - Noor, Nurulamin M; Davies, Neil; Tahir, Warda; Bond, Simon; Dowling, Francis; Patel, Kamal V; Lyons, Paul A; McKinney, Eoin F; Smith, Kenneth G C; Lee, James C; Buchanan, Vanessa; Parkes, Miles; et al. (Journal of Crohn's & Colitis, 2025)